Yujiro Nagata

3PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 01, 2025
Early Experience With Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer.

Akinori Minato, Tomohisa Takaba, Katsuyoshi Higashijima

|Jun 26, 2025
Sodium-Glucose Cotransporter 2 and Glucose Levels Affect Clear Cell Renal Cell Carcinoma Progression.

Yujiro Nagata, Ikko Tomisaki, Hisami Aono

|Sep 28, 2021
Androgen Receptor Signaling Induces Cisplatin Resistance via Down-Regulating GULP1 Expression in Bladder Cancer.

Yuki Teramoto, Guiyang Jiang, Takuro Goto

Pageof 1